Dr. Pamela J. Kirby
Non-Executive Director
DCC
Ireland
Biography
Dr. Pamela J. Kirby, Ph.D., is Non-Executive Director of DCC PLC. She has extensive knowledge of the international healthcare sector, having worked in the pharmaceutical industry for more than twenty five years. Dr. Kirby serves on the board of a FTSE 100 company and is the chairman of a company listed on the NASDAQ stock exchange. She held senior UK and global management positions in AstraZeneca PLC and in F. Hoffman- La Roche Ltd., where she was Director of Global Strategic Marketing. Dr. Kirby is also a former CEO of Quintiles Transnational Corporation in the USA, the leading global provider of biopharmaceutical development and commercial outsourcing services. She was also previously a non-executive director of Novo Nordisk A/S, Informa plc and Smith and Nephew plc. Non-executive Chairman of Scynexis Inc and a non-executive director of Victrex plc, Hikma Pharmaceuticals plc and Reckitt Benckiser Group plc.
Research Interest
Dr. Pamela J. Kirby, Ph.D., is Non-Executive Director of DCC PLC. She has extensive knowledge of the international healthcare sector, having worked in the pharmaceutical industry for more than twenty five years. Dr. Kirby serves on the board of a FTSE 100 company and is the chairman of a company listed on the NASDAQ stock exchange. She held senior UK and global management positions in AstraZeneca PLC and in F. Hoffman- La Roche Ltd., where she was Director of Global Strategic Marketing. Dr. Kirby is also a former CEO of Quintiles Transnational Corporation in the USA, the leading global provider of biopharmaceutical development and commercial outsourcing services. She was also previously a non-executive director of Novo Nordisk A/S, Informa plc and Smith and Nephew plc. Non-executive Chairman of Scynexis Inc and a non-executive director of Victrex plc, Hikma Pharmaceuticals plc and Reckitt Benckiser Group plc.
